在哈萨克斯坦的手术:结果和高级成像的作用
Dina Kalinina1,2, Nazira Bekenova2, Alimzhan Muxunov1,2
1Department of Medicine, School of Medicine, Nazarbayev University, Astana Z05P3Y4, Kazakhstan.
Journal of clinical medicine
|November 27, 2025
概括
中亚的手术在三分之二的成年人中实现了无发作,相当于全球的发作率. 先进的成像显示了多样化的结果,表明有针对性的使用是有利的在低资源的设置.
科学领域:
- 神经外科 神经外科
- 发病学 (Epileptology) 是一个专业的学科.
- 医疗成像医学成像
背景情况:
- 关于中亚手术结果的证据有限,这突显了低收入和中等收入国家面临的挑战.
- 这项研究评估了在哈萨克斯坦进行切除性手术后一年的发作结果.
- 评估了先进的术前成像和发作自由之间的关联.
研究的目的:
- 在中亚队列中,在切除性手术后一年评估发作结果.
- 确定先进的手术前成像对实现无性发作 (恩格尔I类) 的影响.
- 评估手术在低资源环境中的可行性.
主要方法:
- 对112名接受切除性手术的成年患者进行了回顾性队列研究 (2017-2023年).
- 在手术后12个月使用恩格尔标准分类的结果.
- 后勤回归和修改的波桑回归用于分析成像和结果之间的关联.
主要成果:
- 74名患者 (66%) 在一年内实现了无发作 (Engel I).
- 先进的成像方式显示出与结果的不同关联;fMRI使用与更高的Engel I概率有关,而MR光谱与较低的概率有关.
- 不能达到Engel I的预测因素包括普遍的强力克隆性发作,MRI定义的缩,混合性病变以及接受任何高级诊断测试.
结论:
- 该中亚队列中大约三分之二的成年人在整形外科手术后一年内实现了完全无发作,与国际基准保持一致.
- 先进的成像模式显示出与结果的各种关联,可能是由于根据指示的混.
- 这些发现支持了手术在资源有限的环境中的有效性,以及明智地使用先进的成像技术的价值.
更多相关视频
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
3.4K
05:54Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
17.9K
相关概念视频
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: Potassium Channel Activators
613
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
613
